Drug Type Small molecule drug |
Synonyms Risorine |
Target |
Action inhibitors |
Mechanism CYP3A inhibitors(Cytochrome P450 3A inhibitors), P-gp inhibitors(P-glycoprotein 1 inhibitors), RNAP inhibitors(Bacterial DNA-directed RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date India (16 Oct 2009), |
Regulation- |
Molecular FormulaC43H58N4O12 |
InChIKeyJQXXHWHPUNPDRT-ZNQWNCHJSA-N |
CAS Registry13292-46-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Tuberculosis | India | 16 Oct 2009 | |
Pulmonary Tuberculosis | - | - |
Not Applicable | 42 | (Curcumin) | qppbxxfzfn(hkdhexdvog) = jtynvdcxsj mdsxnkuoia (tgdzfjwdga, tfusbiwjso - qgektuswgg) View more | - | 19 Oct 2011 | ||
qppbxxfzfn(hkdhexdvog) = hfqmqxdhvx mdsxnkuoia (tgdzfjwdga, rzzcaxjmzo - ljpjjymmxj) View more |